Loading company…
NOVIGO Pharma develops nanoparticle delivery technology and products for cosmetics and pharmaceuticals.
NOVIGO Pharma develops nanoparticle delivery technology, cosmetic products, and transdermal patches. Founded in 2021, the company is based in Fukuoka, Japan. In May 2026, it raised an undisclosed amount of Series B funding from JIC Venture Growth Investments, SPARX Group, and Sagin Capital & Consulting to support operations, research, and commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in